ALNY   $312.17  0.34% Market Closed After Close 312.17 0.0

Alnylam Pharmaceuticals, Inc.

EMA (20): 2026-01-08 the price crossed down the moving average line and getting closer to the MA, which means that the downside trend weakens.

EMA (50): 2025-12-08 the price crossed down the moving average line and getting closer to the MA, which means that the downside trend weakens.

EMA (100): 2026-01-08 the price crossed down the moving average line and demonstrates a downside trend.

RSI: RSI indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: exit from the overbought zone.

MACD: Oscillator MACD is in the negative territory it's higher than the signal line and falls. These factors mean that negative mood prevails, but this trend does not have a significant strength. Last signal: main and signal line crossing.

Stochastic: The stochastic indicator is in the oversold territory and it falls. These factors indicate that the downside potential still holds even though the market is oversold. Last signal: entry into the oversold zone.

Trend Type turning down
Power medium strength
Trend Pattern
EMA (20) Signals bearish reversal
EMA (20) Yield -21.84%
EMA (20) date of signal Jan. 8, 2026, 3 a.m.
EMA (50) Signals bearish reversal
EMA (50) Yield -27.41%
EMA (50) date of signal Dec. 8, 2025, 3 a.m.
EMA (100) Signals bearish reversal
EMA (100) Yield -21.84%
EMA (100) date of signal Jan. 8, 2026, 3 a.m.
RSI Signals bearish weakening
RSI (14) Yield 0.0
RSI (14) date of signal March 20, 2026, 3 a.m.
MACD Signals bearish recovery
MACD Yield -0.84%
MACD date of signal March 18, 2026, 3 a.m.
Stochastic Signals bearish recovery
Stochastic Yield 0.34%
Stochastic date of signal March 19, 2026, 3 a.m.
Updated March 21, 2026, 11 p.m.